Table 3 This provides sequential association rule metrics for associations between time duration, dosage, and outcomes

Emergency Dept. Visit

40-59mg 2-4 weeks

0.015

2,438

158,871

2.26

<20mg 2-4 weeks

0.015

1,731

109,011

2.33

80+mg 0-2 weeks

0.016

939

56,714

2.42

20-39mg 2-4 weeks

0.017

3,188

191,807

2.46

20-39mg 4-6 weeks

0.017

2,863

170,754

2.48

<20mg 4-6 weeks

0.018

1,666

91,833

2.67

60-80mg 0-2 weeks

0.019

1,796

95,595

2.77

<20mg 0-2 weeks

0.020

2,262

114,732

2.92

40-59mg 0-2 weeks

0.021

3,441

164,099

3.13

20-39mg 0-2 weeks

0.021

4,144

198,259

3.14

Length Two Associations

20-39mg 4-6 weeks and 60-80mg 0-2 weeks

0.021

36

1,742

2.11

<20mg 2-4 weeks and 40-59mg 0-2 weeks

0.022

31

1,390

2.28

20-39mg 2-4 weeks and 60-80mg 0-2 weeks

0.025

33

1,339

2.52

Self-Harm

<20mg 4-6 weeks

<0.0005

<20

91,833

2.28

60-80mg 8-10 weeks

<0.0005

<20

74,958

2.79

40-59mg 2-4 weeks

0.0002

31

158,871

2.97

60-80mg 2-4 weeks

0.0002

20

91,618

3.06

80+mg 0-2 weeks

<0.0005

<20

56,714

3.70

80+mg 8-10 weeks

<0.0005

<20

45,015

3.72

80+mg 2-4 weeks

<0.0005

<20

54,856

3.83

40-59mg 0-2 weeks

0.0003

51

164,083

4.47

80+mg 4-6 weeks

<0.0005

<20

51,995

4.86

60-80mg 0-2 weeks

0.0004

37

95,595

5.52

All-cause Mortality

60-80mg 6-8 weeks

0.0003

20

79,250

2.37

80+mg 2-4 weeks

<0.0005

<20

54,856

2.39

60-80mg 4-6 weeks

0.0003

22

85,658

2.42

80+mg 0-2 weeks

<0.0005

<20

56,714

2.48

40-59mg 0-2 weeks

0.0003

44

164,083

2.55

60-80mg 2-4 weeks

0.0003

26

91,618

2.68

80+mg 10-12 weeks

<0.0005

<20

41,889

2.69

80+mg 4-6 weeks

<0.0005

<20

51,995

2.71

<20mg 0-2 weeks

0.0003

37

114,732

3.06

60-80mg 0-2 weeks

0.0004

34

95,595

3.37